Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CT › Stamford › NPI 1356331425
Physician

Stamford Hospital

Stamford Hospital was paid $139.83M by Medicaid between Jan 2018 and Dec 2024, across 598 billing codes. Its largest line is 99285, emergency room visit (most serious) — 16% of everything it billed.

33Billing provider infoSTAMFORD HOSPITAL
STAMFORD, CT 06902
33aNPI1356331425assigned 10/28/2005
33bProvider typeHospitalist Physician
28Total paid$139.83M
24GClaims4,198,195
24DCodes billed598
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Hospitalist Physician providers in Connecticut

Rank by total paid#1 of 19
Median peer was paid$10K
This provider vs. median13,480×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018573,260$17.33M
2019591,619$18.25M
2020524,961$16.00M
2021607,287$21.80M
2022639,245$22.80M
2023704,296$22.95M
2024incomplete557,527$20.70M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 16% 44,134 35,694 $22.44M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.1% 42,617 35,573 $12.66M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.5% 49,375 42,939 $10.44M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 6.2% 143,066 35,403 $8.61M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 5.7% 81,590 66,081 $7.97M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.1% 32,143 25,997 $4.34M
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 3.0% 3,331 2,825 $4.17M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.0% 15,111 12,637 $2.78M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.7% 11,863 8,991 $2.35M
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.7% 3,257 2,835 $2.32M
77067 Screening mammography, bilateral, including computer-aided detection 1.3% 18,983 17,301 $1.86M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.3% 17,671 8,394 $1.83M
586 more codes
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.3% 57,929 $1.79M
70450 Computed tomography, head or brain; without contrast material 1.3% 14,712 $1.76M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.2% 13,258 $1.69M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.1% 19,375 $1.61M
93975 <1% 6,964 $1.38M
J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg <1% 2,186 $1.31M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 3,177 $1.30M
64493 <1% 1,955 $1.21M
71046 Radiologic examination, chest; 2 views <1% 22,332 $1.20M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 5,863 $1.17M
71045 Radiologic examination, chest; single view <1% 22,551 $1.06M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 1,873 $1.04M
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 9,019 $936K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 1,906 $930K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 103,640 $884K
76641 <1% 16,360 $848K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 1,358 $842K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 14,082 $823K
76830 Ultrasound, transvaginal <1% 8,757 $817K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 9,190 $807K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 36,591 $796K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 29,653 $794K
84443 Thyroid stimulating hormone (TSH) <1% 65,721 $793K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 29,603 $792K
80053 Comprehensive metabolic panel <1% 121,297 $719K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 5,352 $708K
80061 Lipid panel <1% 64,518 $667K
97161 <1% 11,780 $648K
96375 Therapeutic injection; each additional sequential IV push <1% 24,737 $648K
86900 <1% 16,636 $632K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 808 $606K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 2,779 $591K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 2,357 $585K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 183,888 $543K
76818 <1% 4,948 $524K
59025 Fetal non-stress test <1% 3,101 $515K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 8,988 $490K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 3,690 $487K
G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography <1% 1,570 $465K
70551 Magnetic resonance imaging, brain; without contrast material <1% 3,070 $453K
77065 Tomosynthesis, mammo <1% 4,307 $449K
71275 Computed tomographic angiography, chest, with contrast material <1% 3,686 $442K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,587 $428K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 13,059 $405K
88342 <1% 8,213 $400K
70496 <1% 2,007 $380K
83036 Hemoglobin; glycosylated (A1C) <1% 54,449 $375K
11043 <1% 2,475 $368K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 12,606 $347K
76536 <1% 4,601 $308K
76801 <1% 3,139 $300K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 5,409 $298K
76642 <1% 5,518 $291K
19083 <1% 259 $289K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 2,206 $286K
93798 <1% 6,366 $285K
93351 <1% 945 $284K
36415 Collection of venous blood by venipuncture <1% 271,035 $283K
96367 <1% 4,701 $275K
97162 <1% 6,180 $268K
82607 <1% 24,680 $264K
77066 Tomosynthesis, mammo <1% 2,277 $262K
93971 <1% 3,978 $256K
94726 <1% 3,009 $253K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,924 $247K
93970 <1% 2,178 $242K
93458 <1% 175 $240K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,559 $236K
76770 <1% 3,054 $230K
77063 Screening digital breast tomosynthesis, bilateral <1% 18,972 $221K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,235 $218K
77080 <1% 2,619 $217K
47562 <1% 47 $204K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 5,752 $199K
73630 <1% 8,188 $198K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 60,316 $190K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 27,523 $184K
84439 <1% 27,608 $183K
93017 <1% 3,985 $177K
86003 <1% 4,073 $176K
82728 <1% 17,889 $170K
73562 <1% 9,738 $168K
96361 Intravenous infusion, hydration; each additional hour <1% 5,857 $166K
74183 <1% 998 $165K
73030 <1% 7,414 $163K
87088 <1% 45,828 $157K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,325 $156K
86480 <1% 3,782 $155K
J2505 Injection, pegfilgrastim, 6 mg <1% 63 $151K
76819 Fetal biophysical profile; without non-stress testing <1% 1,463 $149K
87510 <1% 9,196 $148K
87480 <1% 9,197 $148K
87660 <1% 9,196 $148K
71250 <1% 2,976 $146K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 19,586 $145K
82746 <1% 14,079 $143K
86803 <1% 14,103 $140K
93976 <1% 1,410 $137K
72110 <1% 3,064 $131K
72141 <1% 861 $131K
97165 <1% 1,695 $122K
92523 <1% 538 $117K
88142 <1% 8,989 $116K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 7,870 $115K
62323 <1% 292 $114K
97116 <1% 5,278 $110K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 8,681 $108K
73221 <1% 617 $106K
83540 <1% 21,754 $103K
84403 <1% 5,664 $102K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 45,642 $102K
86703 <1% 8,830 $97K
72197 <1% 337 $96K
94060 <1% 536 $91K
78815 Positron emission tomography (PET) for limited area imaging <1% 172 $91K
96132 <1% 1,924 $91K
84481 <1% 7,099 $88K
83550 <1% 14,367 $86K
86618 <1% 7,276 $85K
80048 Basic metabolic panel (calcium, ionized) <1% 75,459 $84K
72100 <1% 2,443 $84K
86780 <1% 7,485 $83K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,312 $83K
82670 <1% 3,578 $82K
86696 <1% 5,172 $82K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 812 $81K
94010 <1% 2,680 $80K
74174 <1% 483 $80K
83970 <1% 3,301 $79K
87340 <1% 11,531 $77K
96415 <1% 971 $75K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,589 $74K
85027 <1% 27,770 $73K
86769 <1% 1,957 $71K
83525 <1% 6,732 $70K
73130 <1% 5,039 $69K
87070 <1% 23,638 $66K
83001 <1% 4,272 $65K
81003 <1% 99,598 $64K
44970 <1% 13 $63K
96417 <1% 1,222 $62K
95816 <1% 484 $62K
36430 <1% 999 $61K
83655 <1% 5,404 $59K
86695 <1% 5,172 $56K
83002 <1% 3,560 $55K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 230 $54K
88307 <1% 1,565 $54K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 10,476 $54K
84152 <1% 3,409 $53K
73110 <1% 3,514 $52K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,513 $52K
83013 <1% 965 $51K
84702 <1% 11,184 $51K
P9016 Red blood cells, leukocytes reduced, each unit <1% 608 $50K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,702 $50K
73610 <1% 5,015 $49K
G0379 Direct admission of patient for hospital observation care <1% 173 $49K
72050 <1% 802 $48K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 5,808 $48K
82570 <1% 13,253 $46K
88313 <1% 8,120 $45K
84146 <1% 3,709 $45K
95806 <1% 421 $45K
84270 <1% 2,487 $45K
72070 <1% 1,265 $44K
87631 <1% 3,328 $43K
C8908 Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral <1% 189 $43K
87625 <1% 1,583 $43K
87536 <1% 684 $42K
87186 <1% 13,728 $42K
86141 <1% 3,990 $41K
82105 <1% 3,144 $40K
87077 <1% 13,777 $40K
19081 <1% 28 $40K
82652 <1% 1,453 $39K
86038 <1% 4,345 $39K
87081 <1% 9,910 $39K
70486 <1% 2,057 $38K
84153 <1% 3,816 $38K
82043 <1% 9,207 $38K
72125 Computed tomography, cervical spine; without contrast material <1% 5,641 $38K
29505 <1% 703 $37K
97535 Self-care/home management training, each 15 minutes <1% 1,458 $35K
84144 <1% 2,299 $35K
86706 <1% 4,483 $35K
73502 <1% 2,701 $34K
95811 <1% 47 $34K
73140 <1% 2,874 $33K
85651 <1% 17,981 $33K
96402 <1% 1,024 $32K
82784 <1% 5,553 $32K
80076 <1% 33,949 $32K
83516 <1% 3,226 $31K
83880 <1% 16,503 $31K
84425 <1% 1,981 $31K
73080 <1% 2,485 $31K
83735 <1% 26,210 $30K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 2,550 $29K
83520 <1% 2,695 $29K
86140 <1% 14,288 $29K
97113 <1% 812 $28K
95700 <1% 209 $26K
85730 <1% 23,041 $26K
77061 <1% 3,846 $26K
85610 <1% 37,723 $26K
86709 <1% 3,027 $25K
84466 <1% 2,501 $25K
84402 <1% 1,851 $25K
86787 <1% 3,431 $25K
95250 <1% 568 $24K
82378 <1% 2,705 $24K
86592 <1% 6,717 $24K
86762 <1% 3,812 $24K
77090 <1% 692 $23K
83020 <1% 3,840 $23K
86406 <1% 2,869 $23K
77091 <1% 692 $23K
82627 <1% 1,248 $23K
58558 <1% 15 $23K
76882 <1% 410 $23K
86850 <1% 15,593 $22K
10060 <1% 167 $20K
73560 <1% 1,447 $20K
82533 <1% 1,741 $20K
87147 <1% 9,838 $20K
72131 <1% 474 $20K
83615 <1% 9,428 $19K
86235 <1% 879 $19K
85007 <1% 15,632 $19K
86255 <1% 1,797 $19K
86800 <1% 1,667 $19K
87501 <1% 5,902 $18K
88312 <1% 4,000 $18K
86376 <1% 1,836 $18K
96118 <1% 306 $17K
88112 <1% 1,140 $17K
77062 <1% 2,160 $17K
82985 <1% 1,634 $17K
86360 <1% 538 $17K
70491 <1% 155 $17K
86694 <1% 1,420 $17K
86920 <1% 689 $17K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,581 $16K
86765 <1% 1,586 $16K
10005 <1% 61 $16K
88304 <1% 3,270 $16K
80055 <1% 1,121 $15K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 9,949 $15K
82950 <1% 3,599 $15K
87899 <1% 3,525 $15K
86735 <1% 1,283 $14K
86160 <1% 1,561 $14K
84165 <1% 2,821 $13K
86747 <1% 1,874 $13K
86300 <1% 1,469 $13K
86665 <1% 1,179 $13K
87046 <1% 3,953 $13K
71271 <1% 134 $13K
82951 <1% 1,154 $13K
86430 <1% 2,944 $13K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg <1% 134 $12K
87522 Neg quan hep c or qual rna <1% 435 $12K
74019 <1% 484 $12K
83690 <1% 36,893 $12K
82550 <1% 6,017 $12K
97166 <1% 277 $11K
74018 <1% 2,917 $11K
88300 <1% 1,824 $11K
86413 <1% 228 $11K
73590 <1% 1,803 $11K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 968 $10K
70498 <1% 1,852 $10K
11044 <1% 41 $10K
64635 <1% 21 $10K
85044 <1% 4,005 $10K
70544 <1% 210 $10K
96133 <1% 226 $10K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 8,544 $10K
86617 <1% 966 $10K
71101 <1% 666 $9K
86225 <1% 912 $9K
87478 <1% 514 $9K
87484 <1% 514 $9K
87469 <1% 514 $9K
87468 <1% 514 $9K
86334 <1% 1,223 $9K
83498 <1% 396 $9K
76870 <1% 1,148 $8K
84550 <1% 5,584 $8K
82024 <1% 340 $8K
12001 <1% 1,385 $8K
84156 <1% 3,967 $8K
87338 <1% 808 $8K
84100 <1% 21,288 $8K
83883 <1% 1,684 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 14,696 $8K
86256 <1% 712 $7K
G0378 Hospital observation service, per hour <1% 12,854 $7K
87075 <1% 2,580 $7K
80069 <1% 1,299 $7K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,979 $7K
87640 <1% 2,583 $7K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 9,752 $7K
86364 <1% 773 $7K
29125 <1% 1,861 $7K
87045 <1% 2,002 $7K
12011 <1% 820 $7K
81025 <1% 39,471 $6K
84480 <1% 1,056 $6K
99213 Doctor's office visit, returning patient (routine) <1% 243 $6K
76825 <1% 20 $6K
86258 <1% 725 $6K
81001 <1% 7,529 $6K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 12 $6K
84207 <1% 352 $6K
83521 <1% 1,438 $6K
86664 <1% 596 $6K
93880 <1% 88 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 22,116 $5K
87177 <1% 1,587 $5K
85018 <1% 3,062 $5K
86359 <1% 544 $5K
87185 <1% 13,749 $5K
85014 <1% 3,019 $5K
83721 <1% 806 $5K
82150 <1% 1,348 $5K
80164 <1% 942 $5K
73090 <1% 987 $5K
85379 <1% 5,455 $5K
82248 <1% 2,781 $5K
90686 <1% 374 $5K
84703 <1% 2,107 $5K
86663 <1% 596 $5K
82947 <1% 1,589 $5K
87493 <1% 485 $4K
76813 <1% 2,775 $4K
86901 <1% 16,545 $4K
82247 <1% 1,126 $4K
83090 <1% 356 $4K
84436 <1% 948 $4K
86231 <1% 408 $4K
82952 <1% 1,197 $4K
77336 <1% 87 $4K
80177 <1% 864 $4K
84154 <1% 307 $4K
74220 <1% 31 $4K
82977 <1% 900 $4K
72114 <1% 63 $3K
86708 <1% 333 $3K
82565 <1% 1,250 $3K
87641 <1% 1,079 $3K
36416 <1% 38,692 $3K
84484 <1% 36,950 $3K
78306 <1% 16 $3K
82677 <1% 161 $3K
82785 <1% 260 $3K
86304 <1% 253 $3K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 82 $3K
86677 <1% 176 $3K
29105 <1% 47 $3K
86200 <1% 303 $3K
72040 <1% 127 $3K
96376 <1% 8,184 $3K
29130 <1% 824 $3K
87040 <1% 10,462 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 92 $3K
84305 <1% 142 $3K
97597 <1% 37 $2K
12002 <1% 187 $2K
81050 <1% 1,358 $2K
86336 <1% 176 $2K
94618 <1% 363 $2K
84450 <1% 1,419 $2K
73660 <1% 348 $2K
72170 <1% 97 $2K
86704 <1% 167 $2K
82465 <1% 397 $2K
73700 <1% 16 $1K
99203 Doctor's office visit, new patient (routine) <1% 12 $1K
M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring <1% 26 $1K
83993 <1% 119 $1K
86039 <1% 158 $1K
84181 <1% 106 $1K
84145 <1% 3,184 $1K
92610 <1% 30 $1K
90715 <1% 2,715 $1K
29515 <1% 13 $1K
86146 <1% 71 $1K
87205 <1% 1,959 $1K
72052 <1% 15 $1K
87254 <1% 69 $1K
86301 <1% 119 $1K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,442 $1K
76857 <1% 16 $1K
86147 <1% 63 $1K
83010 <1% 199 $984.82
82166 <1% 39 $891.99
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,678 $859.48
73060 <1% 264 $843.74
82232 <1% 182 $821.62
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 278 $774.08
94762 <1% 34 $757.85
86308 <1% 476 $725.44
86645 <1% 55 $659.69
82948 <1% 39,282 $641.81
97163 <1% 14 $615.00
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source <1% 2,338 $614.55
73521 <1% 21 $613.80
86666 <1% 76 $583.20
96401 <1% 20 $578.67
86644 <1% 55 $563.75
88302 <1% 671 $538.73
84132 <1% 2,147 $512.73
83605 <1% 8,671 $482.32
82274 <1% 40 $471.24
87269 <1% 58 $469.45
86705 <1% 54 $461.25
87272 <1% 57 $458.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 13,620 $449.68
83695 <1% 49 $444.96
82805 <1% 1,333 $438.22
87102 <1% 118 $425.06
87425 <1% 87 $412.20
85397 <1% 29 $394.38
82397 <1% 36 $377.72
80175 <1% 66 $367.14
J3490 Unclassified drugs <1% 50,481 $357.34
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 662 $351.45
90656 <1% 22 $312.90
87563 <1% 14 $294.72
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 9,177 $284.41
86812 <1% 13 $271.15
84460 <1% 1,112 $261.71
84681 <1% 12 $238.44
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 17,967 $217.95
90732 <1% 19 $215.50
85613 <1% 35 $201.08
76376 <1% 752 $200.00
71100 <1% 17 $170.23
82172 <1% 13 $162.80
84432 <1% 15 $153.40
85246 <1% 13 $153.37
85240 <1% 15 $136.80
J7030 Infusion, normal saline solution , 1000 cc <1% 7,959 $133.50
J1650 Injection, enoxaparin sodium, 10 mg <1% 4,119 $131.63
80156 <1% 16 $125.19
A9270 Non-covered item or service <1% 92,168 $115.14
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 19,526 $110.76
J7060 5% dextrose/water (500 ml = 1 unit) <1% 5,864 $110.00
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 1,205 $100.00
83519 <1% 15 $90.00
70360 <1% 47 $88.86
73600 <1% 61 $87.89
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 3,364 $87.70
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 98 $87.15
82010 <1% 830 $84.86
85384 <1% 31 $81.10
81015 <1% 26,875 $79.14
89051 <1% 232 $78.90
82610 <1% 15 $77.88
82085 <1% 12 $75.90
82803 <1% 67 $67.44
88311 <1% 401 $67.21
J3480 Injection, potassium chloride, per 2 meq <1% 592 $66.24
69209 <1% 243 $60.59
J2270 Injection, morphine sulfate, up to 10 mg <1% 8,026 $60.29
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 63 $60.00
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 6,314 $56.88
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 56 $54.60
82523 <1% 13 $53.55
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 472 $49.52
87184 <1% 30 $46.13
A9585 Injection, gadobutrol, 0.1 ml <1% 6,709 $44.36
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 37 $34.35
J8597 Antiemetic drug, oral, not otherwise specified <1% 4,214 $30.41
J3535 Drug administered through a metered dose inhaler <1% 2,980 $30.36
J0780 Injection, prochlorperazine, up to 10 mg <1% 755 $28.19
94664 <1% 1,123 $27.19
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 23,990 $21.62
C9399 Unclassified drugs or biologicals <1% 833 $15.64
J2704 Injection, propofol, 10 mg <1% 23,980 $13.45
S0028 Injection, famotidine, 20 mg <1% 7,485 $13.19
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 2,641 $13.15
J1170 Injection, hydromorphone, up to 4 mg <1% 4,605 $11.25
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 22,652 $11.21
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 9,405 $10.27
J7120 Ringers lactate infusion, up to 1000 cc <1% 18,301 $10.19
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 7,315 $9.38
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,635 $9.02
94760 <1% 3,508 $8.65
82009 <1% 132 $8.62
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 630 $8.61
J0690 Injection, cefazolin sodium, 500 mg <1% 9,245 $8.48
J2060 Injection, lorazepam, 2 mg <1% 3,327 $8.16
C9113 Injection, pantoprazole sodium, per vial <1% 1,097 $7.94
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 15,134 $7.24
84520 <1% 53 $6.94
J3475 Injection, magnesium sulfate, per 500 mg <1% 3,011 $6.81
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 1,131 $4.86
J1836 Injection, metronidazole, 10 mg <1% 167 $4.50
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 926 $3.87
85008 <1% 285 $3.02
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 49 $2.42
J3010 Injection, fentanyl citrate, 0.1 mg <1% 19,398 $2.18
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting <1% 482 $1.88
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 259 $1.13
J1630 Injection, haloperidol, up to 5 mg <1% 686 $0.91
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,628 $0.80
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals <1% 120 $0.55
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 1,703 $0.28
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 1,630 $0.24
J7050 Infusion, normal saline solution, 250 cc 0% 8,739 $0.00
J1815 Injection, insulin, per 5 units 0% 4,126 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 939 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 691 $0.00
64494 0% 2,156 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 1,288 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 2,006 $0.00
88341 0% 937 $0.00
A4648 Tissue marker, implantable, any type, each 0% 1,188 $0.00
C1769 Guide wire 0% 1,577 $0.00
99153 Mod sedat endo service >5yrs 0% 226 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 341 $0.00
88172 0% 96 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 639 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 309 $0.00
G9035 Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project) 0% 48 $0.00
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 0% 453 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 110 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 175 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 176 $0.00
C1781 Mesh (implantable) 0% 58 $0.00
80050 General health panel 0% 89 $0.00
70547 0% 15 $0.00
76820 0% 199 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 71 $0.00
C1773 Retrieval device, insertable (used to retrieve fractured medical devices) 0% 22 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 32 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 53 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 578 $0.00
J0280 Injection, aminophyllin, up to 250 mg 0% 20 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 38 $0.00
76377 0% 14 $0.00
J0706 Injection, caffeine citrate, 5 mg 0% 54 $0.00
94660 0% 19 $0.00
J0697 Injection, sterile cefuroxime sodium, per 750 mg 0% 25 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 116 $0.00
J9045 Injection, carboplatin, 50 mg 0% 24 $0.00
87449 0% 22 $0.00
96368 0% 22 $0.00
64495 0% 1,422 $0.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 0% 3,189 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 1,304 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 4,715 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 463 $0.00
94729 0% 2,884 $0.00
76827 0% 12 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 418 $0.00
J3489 Injection, zoledronic acid, 1 mg 0% 318 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 161 $0.00
93325 0% 606 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 85 $0.00
99152 0% 1,131 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 9,665 $0.00
27096 0% 848 $0.00
C1776 Joint device (implantable) 0% 15 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 244 $0.00
0042T 0% 20 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 191 $0.00
88173 0% 243 $0.00
C1758 Catheter, ureteral 0% 38 $0.00
J7510 Prednisolone oral, per 5 mg 0% 181 $0.00
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 0% 58 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 0% 15 $0.00
C1788 Port, indwelling (implantable) 0% 53 $0.00
76942 0% 82 $0.00
88360 0% 24 $0.00
73551 0% 16 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 18 $0.00
77012 0% 13 $0.00
Q0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg 0% 21 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 22 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 113 $0.00
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) 0% 24 $0.00
73100 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOLBERG, CRIS (EXEC. DIRECTOR - FINANCIAL PLAN & R)